Brief: Palatin Technologies Says Dry Eye Disease Phase 2 Study To Commence Q1 2020
21/01/2020 13:02
Jan 21 (Reuters) - Palatin Technologies Inc PTN.A :
* PALATIN PROVIDES CORPORATE UPDATE AND 2020 CALENDAR
OUTLOOK
* PALATIN TECHNOLOGIES INC - DRY EYE DISEASE PHASE 2 STUDY
TO
COMMENCE Q1 2020
* PALATIN TECHNOLOGIES INC - CASH AND CASH EQUIVALENTS AT
DECEMBER
31, 2019 AMOUNTED TO $92 MILLION
* PALATIN TECHNOLOGIES - PALATIN IS ADVANCING DISCUSSIONS ON
VYLEESI COLLABORATIONS FOR TERRITORIES OUTSIDE CURRENTLY
LICENSED TERRITORIES
Source text for Eikon: ID:nPn9KbHQla
Further company coverage: PTN.A
(((Reuters.Briefs@thomsonreuters.com);))
Recent news on Palatin Technologies
See all newsPalatin Technologies Inc reports results for the quarter ended March 31 - Earnings Summary
Palatin Technologies Inc expected to post a loss of $1.20 a share - Earnings Preview
Palatin Technologies Q2 revenue rises yr/yr, net loss widens
Brief: Palatin Announces 1-For-50 Reverse Stock Split
Brief: Palatin Announces Positive Preclinical Efficacy Data For Oral MC4R Agonist PL7737 In Animal Model Of Obesity